|
|
|
|
| TRADING CENTER |
55.75+0.38 / +0.69%
Celgene Corporation (NASDAQ GS:CELG)
55.750.00 / 0.00
After hours quote
Prev. Close:
55.37
Open:
55.28
High:
55.80
Low:
55.17
Volume:
2,181,300
Volume Avg.:
3,461,500
52wk Range:
36.90 - 58.31
Market Cap (mil):
25,622.81
P/E Ratio:
67.17
Dividend Yield:
N/A
| Dream Stocks for Biotech Investors - MotleyFool.com | |
| Beware the Second Leg of the Next Great Recession - MotleyFool.com | |
| Get Ready for a 25% Drop - MotleyFool.com | |
| Stocks You Can Be Thankful For - MotleyFool.com | |
| Now's a Great Time to Invest -- So Don't Blow It Like This - MotleyFool.com | |
| Critical Alerts For Visa, Schlumberger, Celgene, Illumina, and American Water Works R... - PR Newswire | |
| Celgene Corporation to Present at the Lazard Capital Markets 6th Annual Healthcare Co... - Business Wire | |
| The Life-and-Death Situation That Isn't - MotleyFool.com | |
| More Than 200 Abstracts Evaluating Celgene Products across a Range of Indications to ... - Business Wire | |
| Celgene Corporation to Present at Two Upcoming Investor Conferences - Business Wire | |
| Celgene Corporation to Present at the Oppenheimer & Co. Inc. 20th Annual Healthca... - Business Wire | |
| Schaeffer's Daily Option Blog: Call Trading Skyrockets on Celgene (CELG) - Business Wire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 57.08 | 0.28 / 0.49% | 10.91 |
| GILD | Gilead Sciences Inc | 46.98 | 0.02 / 0.04% | 18.14 |
| BIIB | Biogen Idec Inc | 47.45 | 0.07 / 0.15% | 15.92 |
Short Interest Date:
Oct 30 2009
Short Interest Shares:
7,370,581
Short Interest Ratio:
2.0
Float:
457,030,164
Short Interest as a % of Float:
1.6%
Average Daily Volume:
4,833,700
Outstanding Shares:
459,602,351
Celgene Corporation is a global integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. The company is dedicated to research and development designed to ... (more)
| 2008 Revenue: | $2.3 B | Headquarters: Summit, NJ |
| Employees: | 2,441 | CEO: Dr. Sol J. Barer, Ph.D. |
| Net Income: | $-1,533,653,000.0 | Industry: Biotechnology |
| Market Cap: | $25.2 B | Website: www.celgene.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| CELG | 55.75 | +0.38 / +0.69% | 55.37 | 55.80 | 55.17 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
